/

PRVA

Privia Health Group, Inc.Open

21.72+0.27 +1.26%USD

NasdaqGS · as of Oct 13, 11:21 ET · 15m delay

Open

21.57

Prev close

21.45

Day range

21.3722.05

52-week range

18.9228.82

Volume

560.84K0.45×

Mkt cap

2.77B

P/E ttm

108.60

Fwd P/E

20.43

EPS ttm

0.2000

Div yield

0.00%

Earnings

Nov 5, 2026

From 52w high

−24.64%

Price Chart

Yahoo Finance · delayed

PRVAOct 13, 2026O 21.57H 22.05L 21.37C 21.72+0.27 (+1.26%)Vol 560.84K

SMA 5020.85
SMA 20022.76

1Y change −9.80% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

PRVA Privia Health Group, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +7.10%
1 month: +6.37%
3 months: −22.51%
6 months: −6.06%
Year to date: −8.39%
1 year: −10.03%

Valuation & ownership

Market cap: 2.77B
Enterprise value: 2.39B
P/E (ttm): 108.60
Forward P/E: 20.43
PEG ratio: —
Price / book: 3.51
Price / sales (ttm): 1.18
EV / EBITDA: 42.02
EPS (ttm): 0.2000
EPS (forward): 1.06
Beta (5y monthly): 0.80
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 127.73M
Float: 108.95M
Short % of float: 6.74%
Short ratio (days): 4.48
Held by insiders: 6.19%
Held by institutions: 98.54%
Avg volume (3m): 1.25M
50-day average: 20.89
200-day average: 22.77
52-week change: −10.03%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 66.8
vs 50-day SMA: +4.19%
vs 200-day SMA: −4.56%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.91%
Realised vol (20d, ann.): 23.3%
From 52-week high: −24.64%
From 52-week low: +14.83%

ANR

Analyst Consensus

17 analysts

Consensus

Strong buy

1.39 on a 1 (strong buy) – 5 (sell) scale

Mean target

31.47

+44.89% implied

Low 24.00Median 31.00High 40.00

Recommendation trend

Now17 / 1 / 0
1m ago / 1 /

DES

About Privia Health Group, Inc.

Yahoo Finance profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Sector: Healthcare
Industry: Health Information Services
Employees: 1,226
Headquarters: Arlington, VA, United States
Website: priviahealth.com
Officers: Mr. Parth Mehrotra CEO & Director
Mr. David Mountcastle CPA, MBA Executive VP & CFO
Mr. Edward Christopher Fargis Esq. Executive VP, General Counsel, Chief Legal Officer & Corporate Secretary

SEAS

Seasonality · PRVA

2021–2026 · monthly returns

Strongest month Jun +12.57%Weakest month Sep −9.85%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-2.1	2.3	-13.4	20.8	-13.4	19.6	-8.0	-13.4	-3.9	10.3			−8.4%
2025	16.9	9.3	-10.1	4.6	-3.1	1.1	-15.1	18.0	8.1	-2.4	0.3	-2.7	+21.3%
2024	-12.5	10.7	-12.2	-6.1	-5.6	0.1	19.3	-2.9	-9.6	0.8	17.0	-9.0	−15.1%
2023	19.1	3.3	-1.1	0.1	-9.7	4.6	6.9	-6.0	-12.4	-8.6	-1.7	11.5	+1.4%
2022	-17.7	21.0	3.8	-17.7	9.0	21.5	26.3	8.2	-14.4	-1.7	-28.5	-5.1	−12.2%
2021					-9.9	35.6	-6.5	-28.2	-21.0	9.1	-10.1	12.0	−28.8%

INSD

Insider Activity · PRVA

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

517.3K shares

Sells, 6 months

614.4K shares

Net shares

−97K

Net change in insider shares

−1.20%

Date	Insider	Transaction	Shares	Value
Jul 8, 2026	Mountcastle DavidChief Financial Officer	Sale at price 27.67 per share.	21.3K	$588.68K
Jul 6, 2026	Mountcastle DavidChief Financial Officer	Sale at price 27.57 per share.	600	$16.54K
Jul 5, 2026	Morris Matthew ShawnDirector	Sale at price 27.24 - 27.33 per share.	112.8K	$3.08M
Jul 5, 2026	Morris Matthew ShawnDirector	Conversion of Exercise of derivative security at price 2.00 per share.	112.8K	$225.52K
Jul 1, 2026	Mountcastle DavidChief Financial Officer	Sale at price 27.50 per share.	24.7K	$680.18K
Jun 30, 2026	Morris Matthew ShawnDirector	Sale at price 25.72 - 26.93 per share.	135.5K	$3.57M
Jun 30, 2026	Morris Matthew ShawnDirector	Conversion of Exercise of derivative security at price 2.00 per share.	135.5K	$271.00K
Jun 28, 2026	Morris Matthew ShawnDirector	Sale at price 25.33 per share.	151.3K	$3.83M
Jun 28, 2026	Morris Matthew ShawnDirector	Conversion of Exercise of derivative security at price 2.00 per share.	151.3K	$302.64K
Jun 25, 2026	Mountcastle DavidChief Financial Officer	Sale at price 25.18 per share.	17.2K	$433.00K
Jun 25, 2026	Mountcastle DavidChief Financial Officer	Conversion of Exercise of derivative security at price 2.00 per share.	17.2K	$34.39K
May 19, 2026	Soistman Francis S JrDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	Berberian Lance VDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	Kimmet Pamela O'BrienDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	Cocozza Nancy GDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	King David PDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	Morris Matthew ShawnDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	Mccarthy Thomas ADirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 19, 2026	Ryu JaewonDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
May 11, 2026	Mehrotra ParthChief Executive Officer	Sale at price 22.55 - 22.64 per share.	121.1K	$2.73M

13F

Investors Holding PRVA

latest 13F filings of 29 followed managers

Investors holding PRVA
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$16.3M	0.02%	632.70K	−19%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

PRVA

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

PRVA

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Privia Health Group, Inc.

Seasonality · PRVA

Insider Activity · PRVA

Congress Trades · PRVA

Investors Holding PRVA

Investors Holding PRVA

Congress Trades · PRVA

Insider Activity · PRVA

Seasonality · PRVA

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Privia Health Group, Inc.

Financial Snapshot

Earnings & Dividends

News